Home
>
National Drug Code (NDC)
>
MAXALT-MLT
MAXALT-MLT - 0006-3801-18 - (rizatriptan benzoate)
Drug Information of MAXALT-MLT
| Product NDC: | 0006-3801 |
| Proprietary Name: | MAXALT-MLT |
| Non Proprietary Name: | rizatriptan benzoate |
| Active Ingredient(s): | 10 mg/1 & nbsp; rizatriptan benzoate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MAXALT-MLT
| Product NDC: | 0006-3801 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020865 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980629 |
Package Information of MAXALT-MLT
| Package NDC: | 0006-3801-18 |
| Package Description: | 6 CONTAINER in 1 CARTON (0006-3801-18) > 3 POUCH in 1 CONTAINER > 1 BLISTER PACK in 1 POUCH (0006-3801-01) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
NDC Information of MAXALT-MLT
| NDC Code | 0006-3801-18 |
| Proprietary Name | MAXALT-MLT |
| Package Description | 6 CONTAINER in 1 CARTON (0006-3801-18) > 3 POUCH in 1 CONTAINER > 1 BLISTER PACK in 1 POUCH (0006-3801-01) > 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 0006-3801 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | rizatriptan benzoate |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 19980629 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | RIZATRIPTAN BENZOATE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
